Mono Pharmacare Ltd
MONOPHARMAMono Pharmacare Ltd
MONOPHARMA
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| — | 2.29 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 38.62 | 6.72 | 0.49% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Mono Pharmacare is a distributor and supplier of pharmaceutical products and medicines, providing an extensive array of healthcare products, antibiotics, and more.
Peers
Compare with peersAditya Vision Ltd
Landmark Cars Ltd
Baazar Style Retail Ltd
Bhatia Communications & Retail (India) Ltd
Competent Automobiles Company Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2023 | FY 2024 | TTM | |||
|---|---|---|---|---|---|---|
| Total Revenue | 27.22 | 122.44 | — | |||
Raw Materials | 34.19 | 120.28 | — | |||
| Power & Fuel Cost | 0.01 | 0.04 | ||||
| Employee Cost | 0.54 | 2.62 | ||||
| Selling & Administrative Expenses | 0.84 | 2.14 | ||||
| Operating & Other expenses | -10.11 | -9.15 | ||||
EBITDA | 1.75 | 6.51 | — | |||
| Depreciation/Amortization | 0.05 | 0.12 | — | |||
| PBIT | 1.70 | 6.39 | — | |||
| Interest & Other Items | 0.77 | 3.15 | — | |||
| PBT | 0.93 | 3.24 | — | |||
| Taxes & Other Items | 0.23 | 0.79 | — | |||
| Net Income | 0.70 | 2.45 | — | |||
| EPS | 0.57 | 1.63 | — | |||
| DPS | 0.00 | 0.00 | — | |||
| Payout ratio | 0.00 | 0.00 | — |
Company Updates
Peers & Comparison
Consumer DiscretionaryRetail - Speciality
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Mono Pharmacare Ltd | 26.32 | 2.29 | — |
| Aditya Vision Ltd | 72.94 | 11.55 | 0.32% |
| Landmark Cars Ltd | 47.87 | 4.95 | 0.23% |
| Baazar Style Retail Ltd | 114.73 | 11.70 | — |
Price Comparison
Compare MONOPHARMA with any stock or ETFShareholdings
Promoter Holdings Trend
Institutional Holdings Trend
Decreased Total Retail Holding
In last 3 months, retail holding in the company has decreased by 2.63%
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Aug 2023
Sep 2023
Dec 2023
Mar 2024
Shareholding History
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
MONOPHARMA has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeMono Pharmacare will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live
Mono Pharmacare announced that the 2nd Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live
Mono Pharmacare will hold a meeting of the Board of Directors of the Company on 6 September 2024.Powered by Capital Market - Live
Mono Pharmacare will hold a meeting of the Board of Directors of the Company on 6 August 2024.Powered by Capital Market - Live
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant